Cargando…
Establishment and evaluation of cell and animal models expressing BORIS subfamily 2 variant
BACKGROUND: The possibility of a cancer vaccine aimed at stimulating or mobilizing the body’s immune system to control and kill tumor cells is emerging as a potential new strategy for tumor immunological therapy. CCCTC-binding Factor Like (CTCFL)/Brother of the Regulator of Imprinted Sites (BORIS),...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263788/ https://www.ncbi.nlm.nih.gov/pubmed/35813346 http://dx.doi.org/10.21037/atm-21-6336 |